Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SCPS | AZN | AMGN | GILD | VRTX |
| Company | Scopus Biopharma Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0004 | 91.09 | 327.52 | 119.27 | 453.83 |
| High | 0.0004 | 91.25 | 329.98 | 120.39 | 456.05 |
| Low | 0.0004 | 90.77 | 325.79 | 118.58 | 451.22 |
| Latest | 0.0004 | 90.89 | 328.92 | 120.14 | 451.16 |
| Change | -0.0002 | -0.46 | +2.18 | +1.36 | -3.80 |
| % Change | -33.33% | -0.50% | +0.67% | +1.14% | -0.84% |
| Volume | 1,400 | 2,212,121 | 694,752 | 2,044,670 | 350,033 |
| 20-Day Average Volume | 6,235 | 5,655,163 | 2,763,061 | 6,838,892 | 1,353,806 |
| Previous Close | 0.0006 | 91.35 | 326.74 | 118.78 | 454.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0004 | 90.89 | 331.98 | 123.33 | 440.42 |
| 20-Day Raw Stochastic | 1.03% | 45.32% | 49.40% | 18.52% | 73.07% |
| 20-Day Relative Strength | 49.14 | 57.40 | 54.50 | 47.23 | 58.35 |
| Weighted Alpha | -14.29 | +41.45 | +25.49 | +26.29 | +12.63 |
| Today's Opinion | 40% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 8% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 64% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/02/25 | -0.61% since 12/10/25 | +4.38% since 12/10/25 | -1.01% since 12/10/25 | +1.58% since 12/10/25 |
| Low | 0.0004 on 12/11/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 442.07 on 12/11/25 |
| High | 0.0006 on 12/09/25 | 91.79 on 12/15/25 | 329.80 on 12/17/25 | 123.74 on 12/11/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | unch since 11/10/25 | +1.73% since 11/17/25 | -3.67% since 11/17/25 | -3.20% since 11/17/25 | +4.06% since 11/17/25 |
| Low | 0.0004 on 12/11/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 0.0006 on 12/09/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +33.33% since 09/08/25 | +17.07% since 09/17/25 | +19.83% since 09/17/25 | +7.00% since 09/17/25 | +16.66% since 09/17/25 |
| Low | 0.0003 on 10/30/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.0100 on 11/05/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +33.33% since 06/11/25 | +28.15% since 06/17/25 | +13.49% since 06/17/25 | +11.22% since 06/17/25 | +2.18% since 06/17/25 |
| Low | 0.0003 on 10/30/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 0.0100 on 11/05/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 17 | 283,315,264 | 175,943,280 | 147,367,984 | 115,431,992 |
| Shares Outstanding, K | 42,080 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -11,610,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -2,620,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.27 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 01/01/70 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.03 | 14.87 | 14.63 | 29.77 |